Diclofenac eye drops are used to prevent miosis in and treat inflammations after cataract extraction, treat non-infectious eye inflammations caused or not caused by surgeries, prevent postoperative inflammatory reactions and the formation of
cystoid macular edema, promote the formation of filtration blebs after glaucoma filtering surgeries, and treat allergic conjunctivitis.
The most common ocular adverse reactions in subjects treated with DEXTENZA were: anterior chamber inflammation including iritis and iridocyclitis (10%), increased intraocular pressure (6%), reduced visual acuity (2%),
cystoid macular edema (1%), corneal edema (1%), eye pain (1%), and conjunctival hyperemia (1%).
The most common ocular adverse reactions in subjects treated with Dextenza were: anterior chamber inflammation including iritis and iridocyclitis, increased intraocular pressure, reduced visual acuity,
cystoid macular edema, corneal edema, eye pain, and conjunctival hyperemia.
Omeros Corporation announced the results of a real-world clinical study showing that its FDA-approved ophthalmic drug OMIDRIA 1% / 0.3% decreases the incidence of postoperative
cystoid macular edema, a sight-threatening complication of cataract surgery.
Despite all developments in phacoemulsification surgery,
cystoid macular edema (CME) is still a common reason of a poor visual outcome of uncomplicated cataract surgery (1, 2).
Surgeon must be aware of the following factors before taking on surgery in such compromised eyes: conjunctival scarring, low endothelial cell counts, poor pupillary dilatation, increased lens-iris diaphragm retropulsion, zonular weakness and pre-existing posterior capsular damage as well as diabetic retinopathy, low scleral rigidity,
cystoid macular edema and other co-morbidities.
In our study, incidence of serous oedema was 61.54% and
cystoid was 38.64%.
In addition, they reported greater retinal thickness in the operated eyes and stated that surgery in these eyes could cause a predisposition for
cystoid macular edema.
There were no corneal endothelial decompensation, IOL decentration or dislocation, secondary glaucoma, endophthalmitis,
cystoid macular edema, choroid and retinal detachment, and other ocular complications.
However, Nd:YAG laser capsulotomy can cause certain complications, like
cystoid macular edema, retinal detachment and elevation of intraocular pressure (IOP) after the procedure, which can be significant and can result in irreversible visual loss7.
These eyes may have a higher incidence of
cystoid macular edema (CME) and more pronounced postoperative inflammation than the non-diabetic eyes [19, 20].
Post-operative uveitis,
cystoid macular oedema, relevant retinal fluid, retinal detachment and endophthalmitis were not reported in this cohort.